Atossa Genetics is a healthcare company focused on the development of locally-administered pharmaceuticals for the treatment of pre-cancer and early stage breast cancer.
Atossa Genetics Completes Sale of Its Wholly-Owned Subsidiary, NRLBH
Atossa Genetics Announces Third Quarter 2015 Financial Results and Provides Company Update
Atossa Genetics to Announce Third Quarter 2015 Financial results and Provide a Company Update on Thursday, November 12, 2015
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!